BioNTech Forges Ahead in Oncology, Infectious Disease
BioNTech continues to build on the success of the mRNA COVID-19 vaccine and is rapidly expanding its investigational pipeline to include infectious diseases and oncology.
Source: biospace.com
Stay updated with breaking news from Andreas Arnold Getty. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
BioNTech continues to build on the success of the mRNA COVID-19 vaccine and is rapidly expanding its investigational pipeline to include infectious diseases and oncology.